Providence School Board President Erlin Rogel said the said the board received a presentation on the district’s recent ...

Thompson School District staff presented data and analysis of the district’s most recent statewide assessments to the ...

Ferring Pharmaceuticals and its clinical development partner, Seikagaku Corporation (Seikagaku), today announced they will be presenting an analysis of data at the North American Spine Society’s (NASS ...

Despite our protestations, Microsoft is determined to make AI tools in the workplace accessible and appealing with a raft of ...

UNION therapeutics A/S (UNION), a privately held, clinical stage, pharmaceutical development company focused on immunology, today announced ADESOS Phase 2b results selected as a late-breaking oral ...

Neuraptive Therapeutics Inc., a leading biopharmaceutical company focused on novel treatments for peripheral nerve injuries, ...

Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing ...

The HIMALAYA study showed that the combination of tremelimumab and durvalumab significantly improved overall survival in ...

Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today a ...

The ESMO Congress 2024 will take place from September 13 to 17 in Barcelona, Spain, at the Fira Barcelona Gran Via. BostonGene session details are as follows: Abstract: 1115P Title: Multiomics ...

Subcutaneous and intravenous forms of rituximab showed similar efficacy in patients with non-Hodgkin lymphoma.